The burgeoning popularity of Semaglutide for size loss has sparked considerable interest both within the medical realm and among the general public. Initially approved for treating type 2 diabetes, its remarkable capacity to promote noticeable body reduction has led to its off-label application by many. Clinical studies have demonstrated that copyr